In the midst of the budget turmoil (see separate article), the EU, on Monday 16 November, took advantage of some good news: it is preparing to authorise, from Tuesday 17 November, a new contract with the German start-up CureVac to pre-order up to 405 million doses of its candidate vaccine.
“This is our fifth contract with the pharmaceutical industry”, said the President of the European Commission, Ursula von der Leyen, in a pre-recorded video message. “We do not know at this...